JP2007530462A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007530462A5 JP2007530462A5 JP2007504251A JP2007504251A JP2007530462A5 JP 2007530462 A5 JP2007530462 A5 JP 2007530462A5 JP 2007504251 A JP2007504251 A JP 2007504251A JP 2007504251 A JP2007504251 A JP 2007504251A JP 2007530462 A5 JP2007530462 A5 JP 2007530462A5
- Authority
- JP
- Japan
- Prior art keywords
- chol
- popc
- dmpc
- mochol
- dppc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200410016020 DE102004016020A1 (de) | 2004-03-28 | 2004-03-28 | Serumstabile amphotere Liposomen |
| DE102004054730A DE102004054730A1 (de) | 2004-03-28 | 2004-11-05 | Serumstabile amphotere Liposomen |
| PCT/DE2005/000589 WO2005094783A2 (de) | 2004-03-28 | 2005-03-29 | Serumstabile amphotere liposomen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007530462A JP2007530462A (ja) | 2007-11-01 |
| JP2007530462A5 true JP2007530462A5 (enExample) | 2008-05-15 |
Family
ID=34980311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007504251A Pending JP2007530462A (ja) | 2004-03-28 | 2005-03-29 | 血清に安定な両性リポソーム |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8236770B2 (enExample) |
| EP (1) | EP1734928A2 (enExample) |
| JP (1) | JP2007530462A (enExample) |
| AU (1) | AU2005229485A1 (enExample) |
| CA (1) | CA2561247C (enExample) |
| DE (1) | DE102004054730A1 (enExample) |
| WO (1) | WO2005094783A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8815599B2 (en) * | 2004-06-01 | 2014-08-26 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
| US20060229267A1 (en) * | 2004-06-01 | 2006-10-12 | Reza Sheikhnejad | Methods and compositions for the inhibition of gene expression |
| CA2586708A1 (en) * | 2004-11-05 | 2006-05-11 | Novosom Ag | Improvements in or relating to pharmaceutical compositions comprising an oligonucleotide as an active agent |
| JP2008520600A (ja) * | 2004-11-19 | 2008-06-19 | ノヴォソム アクチェンゲゼルシャフト | 局所投与のための医薬組成物におけるまたはそれに関する改善 |
| EP1764090A1 (en) * | 2005-09-15 | 2007-03-21 | Novosom AG | Amphoteric liposomes for local drug applications |
| WO2007107304A2 (en) * | 2006-03-17 | 2007-09-27 | Novosom Ag | An efficient method for loading amphoteric liposomes with nucleic acid active substances |
| US8017159B2 (en) * | 2005-11-16 | 2011-09-13 | Idexx Laboratories, Inc. | Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| JP5623016B2 (ja) | 2005-12-01 | 2014-11-12 | プロネイ・セラピューティクス・インコーポレイテッドＰｒｏｎａｉｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | 癌治療法およびそれに用いる医薬組成物 |
| JP5122474B2 (ja) * | 2005-12-01 | 2013-01-16 | プロネイ・セラピューティクス・インコーポレイテッド | 両性リポソーム製剤 |
| EP2462924A3 (en) * | 2006-10-13 | 2013-01-23 | Marina Biotech, Inc. | Improvements in or relating to amphoteric liposomes. |
| AU2008309880B2 (en) * | 2007-10-12 | 2014-07-10 | Biontech Delivery Technologies Gmbh | Amphoteric liposomes comprising neutral lipids |
| GB0720486D0 (en) * | 2007-10-19 | 2007-11-28 | Univ Edinburgh | Cationic lipids |
| CN102112110A (zh) * | 2008-06-06 | 2011-06-29 | 米尔纳医疗股份有限公司 | 用于RNAi试剂体内递送的新型组合物 |
| CA2823182C (en) * | 2010-12-30 | 2016-02-23 | Samyang Biopharmaceuticals Corporation | Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof |
| WO2012109495A1 (en) | 2011-02-09 | 2012-08-16 | Metabolic Solutions Development Company, Llc | Cellular targets of thiazolidinediones |
| KR20150087270A (ko) | 2012-11-05 | 2015-07-29 | 프로나이 테라퓨틱스, 인코포레이티드 | Bcl2 발현 조절에 의한 암치료용 바이오마커 이용 방법 |
| WO2016125163A1 (en) * | 2015-02-04 | 2016-08-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | LIPID ASSEMBLIES AND USES THEREOF AND SOME pH AND ELECTROSTATIC MODULATING LIPIDS TO BE USED IN SAID ASSEMBLIES |
| CA3071968A1 (en) | 2017-08-04 | 2019-02-07 | Kyowa Kirin Co., Ltd. | Nucleic acid-containing lipid nanoparticle |
| BR112022020407A2 (pt) | 2020-04-09 | 2023-05-02 | Verve Therapeutics Inc | Edição base do pcsk9 e métodos de uso do mesmo para tratamento de doenças |
| EP4213882A4 (en) | 2020-09-15 | 2025-02-26 | Verve Therapeutics, Inc. | LIPID FORMULATIONS FOR GENE EDITING |
| CN118001254B (zh) | 2024-04-09 | 2024-07-26 | 北京悦康科创医药科技股份有限公司 | 靶向抗原呈递细胞的脂质组合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6649780B1 (en) * | 1998-12-22 | 2003-11-18 | Valentis, Inc. | Cationic lipids |
| DE10109897A1 (de) | 2001-02-21 | 2002-11-07 | Novosom Ag | Fakultativ kationische Liposomen und Verwendung dieser |
| DE10207178A1 (de) | 2002-02-19 | 2003-09-04 | Novosom Ag | Komponenten für die Herstellung amphoterer Liposomen |
| JP2008520600A (ja) * | 2004-11-19 | 2008-06-19 | ノヴォソム アクチェンゲゼルシャフト | 局所投与のための医薬組成物におけるまたはそれに関する改善 |
-
2004
- 2004-11-05 DE DE102004054730A patent/DE102004054730A1/de not_active Ceased
-
2005
- 2005-03-29 US US10/594,553 patent/US8236770B2/en not_active Expired - Fee Related
- 2005-03-29 EP EP05740433A patent/EP1734928A2/de not_active Withdrawn
- 2005-03-29 WO PCT/DE2005/000589 patent/WO2005094783A2/de not_active Ceased
- 2005-03-29 JP JP2007504251A patent/JP2007530462A/ja active Pending
- 2005-03-29 CA CA2561247A patent/CA2561247C/en not_active Expired - Fee Related
- 2005-03-29 AU AU2005229485A patent/AU2005229485A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007530462A5 (enExample) | ||
| CA2748520A1 (en) | Pharmaceutical composition containing an anionic drug, and a production method therefor | |
| WO2010041255A3 (en) | Liposomal systems comprising sphingomyelin | |
| JP2020023585A (ja) | 免疫細胞へオリゴヌクレオチドを送達する方法 | |
| NZ703532A (en) | Methods of treating arthritis | |
| WO2012153338A3 (en) | Liposomes comprising polymer-conjugated lipids and related uses | |
| JP2022518504A (ja) | 閉端ｄｎａ（ｃｅｄｎａ）ならびに遺伝子療法または核酸療法に関連する免疫応答を低減させる方法における使用 | |
| WO2008109031A3 (en) | Liposome carriers for in vivo delivery of fullerenes | |
| RU2014120216A (ru) | Комбинационные липосомальные композиции для лечения рака | |
| JP2009528340A5 (enExample) | ||
| WO2012021107A3 (en) | A liposomal formulation for ocular drug delivery | |
| RU2635460C2 (ru) | Средство для лечения фиброза почек | |
| BR112012029628A2 (pt) | formulações lipossômicas melhoradas de compostos lipofílicos | |
| KR20140097276A (ko) | 약물 전달을 위한 지질 나노입자 생산 방법 | |
| JP7325327B2 (ja) | インフュージョンリアクションを改善するための方法 | |
| WO2011092708A3 (en) | Liposomes comprising amphipathic drugs and method for their preparation | |
| RU2014117690A (ru) | Композиции и способы для сайленсинга альдегид-дегидрогеназы | |
| EP2410988A1 (en) | Pharmaceutical composition containing a drug and sirna | |
| JP2016513651A5 (enExample) | ||
| JP2012532839A5 (enExample) | ||
| US12138345B2 (en) | Delivery of agents using metastable liposomes | |
| Ho et al. | Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model | |
| TW201701887A (zh) | 抗伊波拉（Ｅｂｏｌａ）病毒之ＲＮＡ干擾治療劑 | |
| CN105434437A (zh) | 一种奥沙利铂和伊立替康类药物共载脂质体及其制备方法 | |
| KR20250094676A (ko) | 안티-센스 올리고뉴클레오티드 전달을 위한 지질 나노입자 제형 |